Psychedelics, mystical experience, and therapeutic efficacy: A systematic review

K Ko, G Knight, JJ Rucker, AJ Cleare - Frontiers in psychiatry, 2022 - frontiersin.org
The mystical experience is a potential psychological mechanism to influence outcome in
psychedelic therapy. It includes features such as oceanic boundlessness, ego dissolution …

[HTML][HTML] Pharmacological, neural, and psychological mechanisms underlying psychedelics: A critical review

M van Elk, DB Yaden - Neuroscience & Biobehavioral Reviews, 2022 - Elsevier
This paper provides a critical review of several possible mechanisms at different levels of
analysis underlying the effects and therapeutic potential of psychedelics. At the (1) …

Increased global integration in the brain after psilocybin therapy for depression

RE Daws, C Timmermann, B Giribaldi, JD Sexton… - Nature medicine, 2022 - nature.com
Psilocybin therapy shows antidepressant potential, but its therapeutic actions are not well
understood. We assessed the subacute impact of psilocybin on brain function in two clinical …

Trial of psilocybin versus escitalopram for depression

R Carhart-Harris, B Giribaldi, R Watts… - … England Journal of …, 2021 - Mass Medical Soc
Background Psilocybin may have antidepressant properties, but direct comparisons
between psilocybin and established treatments for depression are lacking. Methods In a …

Must psilocybin always “assist psychotherapy”?

GM Goodwin, E Malievskaia, GA Fonzo… - American Journal of …, 2024 - psychiatryonline.org
Design Open-label Randomized Randomized, double-blind, placebo-controlled
Randomized, double-blind, placebo-controlled Randomized, double-blind, placebo …

Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review

JJ Breeksema, BW Kuin, J Kamphuis… - Journal of …, 2022 - journals.sagepub.com
Introduction: Small-scale clinical studies with psychedelic drugs have shown promising
results for the treatment of several mental disorders. Before psychedelics become registered …

Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders

FX Vollenweider, KH Preller - Nature Reviews Neuroscience, 2020 - nature.com
Renewed interest in the use of psychedelics in the treatment of psychiatric disorders
warrants a better understanding of the neurobiological mechanisms underlying the effects of …

The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world

R Watts, H Kettner, D Geerts, S Gandy, L Kartner… - …, 2022 - Springer
Rationale A general feeling of disconnection has been associated with mental and
emotional suffering. Improvements to a sense of connectedness to self, others and the wider …

Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer

GI Agin-Liebes, T Malone, MM Yalch… - Journal of …, 2020 - journals.sagepub.com
Background: A recently published randomized controlled trial compared single-dose
psilocybin with single-dose niacin in conjunction with psychotherapy in participants with …

Predicting reactions to psychedelic drugs: A systematic review of states and traits related to acute drug effects

JS Aday, AK Davis, CM Mitzkovitz… - ACS Pharmacology & …, 2021 - ACS Publications
Psychedelic drugs are increasingly being incorporated into therapeutic contexts for the
purposes of promoting mental health. However, they can also induce adverse reactions in …